|1||NCT02867020||Recruiting||Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels||
||Other / Industry||
||126||Male||18 Years and older (Adult, Senior)||NCT02867020||LACOG 0415||October 11, 2017||August 2018||January 2020||August 15, 2016||October 18, 2017||
|Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy||
||1195||Male||18 Years and older (Adult, Senior)||NCT00638690||CR016924
|May 2008||August 2010||October 2012||March 19, 2008||April 30, 2014||May 16, 2013||
† Study has passed its completion date and status has not been verified in more than two years.